The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Membrane Technology in Pharma, Biopharma, And Life Science-Global Market Insights and Sales Trends 2025
Synopsis
Membrane technology is a separation process by using specific semi-permeable membrane filters to fractionate or concentrate a liquid converted into two liquids forms. It has transformed from laboratory development to demonstrated industrial applications. Membranes are used extensively for, potable water production, desalination, water reclamation, treating industrial effluents, and reuse.
The global Membrane Technology in Pharma, Biopharma, And Life Science market size is expected to reach US$ 15500 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Membrane Technology in Pharma, Biopharma, And Life Science in various end use industries. The expanding demands from the Pharmaceutical, Biopharmaceuticals and Life Sciences,, are propelling Membrane Technology in Pharma, Biopharma, And Life Science market. Ultrafiltration, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microfiltration segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Membrane Technology in Pharma, Biopharma, And Life Science, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Membrane Technology in Pharma, Biopharma, And Life Science market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Membrane Technology in Pharma, Biopharma, And Life Science market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Membrane Technology in Pharma, Biopharma, And Life Science sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Membrane Technology in Pharma, Biopharma, And Life Science covered in this report include GE Healthcare Life Sciences, Pall Corporation, Amazon Filters, Advantec MFS, Sartorius, 3M Company, Novasep, Merck Millipore and TriSep Corporation, etc.
The global Membrane Technology in Pharma, Biopharma, And Life Science market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare Life Sciences
Pall Corporation
Amazon Filters
Advantec MFS
Sartorius
3M Company
Novasep
Merck Millipore
TriSep Corporation
Koch Membrane Systems
Global Membrane Technology in Pharma, Biopharma, And Life Science market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Membrane Technology in Pharma, Biopharma, And Life Science market, Segment by Type:
Ultrafiltration
Microfiltration
Nanofiltration
Chromatography
Others
Global Membrane Technology in Pharma, Biopharma, And Life Science market, by Application
Pharmaceutical
Biopharmaceuticals
Life Sciences
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Membrane Technology in Pharma, Biopharma, And Life Science companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Membrane technology is a separation process by using specific semi-permeable membrane filters to fractionate or concentrate a liquid converted into two liquids forms. It has transformed from laboratory development to demonstrated industrial applications. Membranes are used extensively for, potable water production, desalination, water reclamation, treating industrial effluents, and reuse.
The global Membrane Technology in Pharma, Biopharma, And Life Science market size is expected to reach US$ 15500 million by 2029, growing at a CAGR of 5.3% from 2023 to 2029. The market is mainly driven by the significant applications of Membrane Technology in Pharma, Biopharma, And Life Science in various end use industries. The expanding demands from the Pharmaceutical, Biopharmaceuticals and Life Sciences,, are propelling Membrane Technology in Pharma, Biopharma, And Life Science market. Ultrafiltration, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Microfiltration segment is estimated at % CAGR for the next seven-year period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Membrane Technology in Pharma, Biopharma, And Life Science, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Membrane Technology in Pharma, Biopharma, And Life Science market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Membrane Technology in Pharma, Biopharma, And Life Science market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Membrane Technology in Pharma, Biopharma, And Life Science sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Membrane Technology in Pharma, Biopharma, And Life Science covered in this report include GE Healthcare Life Sciences, Pall Corporation, Amazon Filters, Advantec MFS, Sartorius, 3M Company, Novasep, Merck Millipore and TriSep Corporation, etc.
The global Membrane Technology in Pharma, Biopharma, And Life Science market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
GE Healthcare Life Sciences
Pall Corporation
Amazon Filters
Advantec MFS
Sartorius
3M Company
Novasep
Merck Millipore
TriSep Corporation
Koch Membrane Systems
Global Membrane Technology in Pharma, Biopharma, And Life Science market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Membrane Technology in Pharma, Biopharma, And Life Science market, Segment by Type:
Ultrafiltration
Microfiltration
Nanofiltration
Chromatography
Others
Global Membrane Technology in Pharma, Biopharma, And Life Science market, by Application
Pharmaceutical
Biopharmaceuticals
Life Sciences
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Membrane Technology in Pharma, Biopharma, And Life Science companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Membrane Technology in Pharma, Biopharma, And Life Science
1.1 Membrane Technology in Pharma, Biopharma, And Life Science Market Overview
1.1.1 Membrane Technology in Pharma, Biopharma, And Life Science Product Scope
1.1.2 Membrane Technology in Pharma, Biopharma, And Life Science Market Status and Outlook
1.2 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Region (2018-2029)
1.4 Global Membrane Technology in Pharma, Biopharma, And Life Science Historic Market Size by Region (2018-2023)
1.5 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
1.6.1 North America Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
1.6.2 Europe Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
1.6.3 Asia-Pacific Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
1.6.4 Latin America Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
1.6.5 Middle East & Africa Membrane Technology in Pharma, Biopharma, And Life Science Market Size (2018-2029)
2 Membrane Technology in Pharma, Biopharma, And Life Science Market by Type
2.1 Introduction
2.1.1 Ultrafiltration
2.1.2 Microfiltration
2.1.3 Nanofiltration
2.1.4 Chromatography
2.1.5 Others
2.2 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Membrane Technology in Pharma, Biopharma, And Life Science Historic Market Size by Type (2018-2023)
2.2.2 Global Membrane Technology in Pharma, Biopharma, And Life Science Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Type (2018-2029)
3 Membrane Technology in Pharma, Biopharma, And Life Science Market Overview by Application
3.1 Introduction
3.1.1 Pharmaceutical
3.1.2 Biopharmaceuticals
3.1.3 Life Sciences
3.2 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Membrane Technology in Pharma, Biopharma, And Life Science Historic Market Size by Application (2018-2023)
3.2.2 Global Membrane Technology in Pharma, Biopharma, And Life Science Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Membrane Technology in Pharma, Biopharma, And Life Science Revenue Breakdown by Application (2018-2029)
4 Membrane Technology in Pharma, Biopharma, And Life Science Competition Analysis by Players
4.1 Global Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Membrane Technology in Pharma, Biopharma, And Life Science as of 2022)
4.3 Date of Key Players Enter into Membrane Technology in Pharma, Biopharma, And Life Science Market
4.4 Global Top Players Membrane Technology in Pharma, Biopharma, And Life Science Headquarters and Area Served
4.5 Key Players Membrane Technology in Pharma, Biopharma, And Life Science Product Solution and Service
4.6 Competitive Status
4.6.1 Membrane Technology in Pharma, Biopharma, And Life Science Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 GE Healthcare Life Sciences
5.1.1 GE Healthcare Life Sciences Profile
5.1.2 GE Healthcare Life Sciences Main Business
5.1.3 GE Healthcare Life Sciences Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.1.4 GE Healthcare Life Sciences Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.1.5 GE Healthcare Life Sciences Recent Developments
5.2 Pall Corporation
5.2.1 Pall Corporation Profile
5.2.2 Pall Corporation Main Business
5.2.3 Pall Corporation Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.2.4 Pall Corporation Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.2.5 Pall Corporation Recent Developments
5.3 Amazon Filters
5.3.1 Amazon Filters Profile
5.3.2 Amazon Filters Main Business
5.3.3 Amazon Filters Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.3.4 Amazon Filters Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.3.5 Advantec MFS Recent Developments
5.4 Advantec MFS
5.4.1 Advantec MFS Profile
5.4.2 Advantec MFS Main Business
5.4.3 Advantec MFS Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.4.4 Advantec MFS Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.4.5 Advantec MFS Recent Developments
5.5 Sartorius
5.5.1 Sartorius Profile
5.5.2 Sartorius Main Business
5.5.3 Sartorius Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.5.4 Sartorius Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.5.5 Sartorius Recent Developments
5.6 3M Company
5.6.1 3M Company Profile
5.6.2 3M Company Main Business
5.6.3 3M Company Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.6.4 3M Company Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.6.5 3M Company Recent Developments
5.7 Novasep
5.7.1 Novasep Profile
5.7.2 Novasep Main Business
5.7.3 Novasep Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.7.4 Novasep Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.7.5 Novasep Recent Developments
5.8 Merck Millipore
5.8.1 Merck Millipore Profile
5.8.2 Merck Millipore Main Business
5.8.3 Merck Millipore Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.8.4 Merck Millipore Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.8.5 Merck Millipore Recent Developments
5.9 TriSep Corporation
5.9.1 TriSep Corporation Profile
5.9.2 TriSep Corporation Main Business
5.9.3 TriSep Corporation Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.9.4 TriSep Corporation Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.9.5 TriSep Corporation Recent Developments
5.10 Koch Membrane Systems
5.10.1 Koch Membrane Systems Profile
5.10.2 Koch Membrane Systems Main Business
5.10.3 Koch Membrane Systems Membrane Technology in Pharma, Biopharma, And Life Science Products, Services and Solutions
5.10.4 Koch Membrane Systems Membrane Technology in Pharma, Biopharma, And Life Science Revenue (US$ Million) & (2018-2023)
5.10.5 Koch Membrane Systems Recent Developments
6 North America
6.1 North America Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Membrane Technology in Pharma, Biopharma, And Life Science Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Membrane Technology in Pharma, Biopharma, And Life Science Market Dynamics
11.1 Membrane Technology in Pharma, Biopharma, And Life Science Industry Trends
11.2 Membrane Technology in Pharma, Biopharma, And Life Science Market Drivers
11.3 Membrane Technology in Pharma, Biopharma, And Life Science Market Challenges
11.4 Membrane Technology in Pharma, Biopharma, And Life Science Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
